A Phase II Efficacy Study in Fistulizing Crohn's Disease Patients

Predictive Factors of ANTI-TNF Response in Luminal Crohn's Disease Complicated by Abscess

NCT02856763 ·Status: COMPLETED

A Phase I Study of Etrolizumab Followed by Open-Label Extension and Safety Monitoring in Pediatric Patients With Moderate to Severe Ulcerative Colitis or Moderate to Severe Crohn's Disease

NCT03478956 ·Status: TERMINATED ·Phase: PHASE1

A Study to Investigate the Efficacy and Safety of GSK1605786 for Treatment of Patients With Active Ulcerative Colitis

NCT01658605 ·Status: WITHDRAWN ·Phase: PHASE2

An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease

NCT01536418 ·Status: TERMINATED ·Phase: PHASE3

A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease

NCT01277666 ·Status: COMPLETED ·Phase: PHASE3

A Study Testing How BI 655130 Works in Patients With Fistulizing Crohn's Disease

NCT03752970 ·Status: COMPLETED ·Phase: PHASE2

Immunological Characteristics of Preclinical IBD

NCT05698745 ·Status: RECRUITING

A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease

NCT05347095 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD)

NCT00805766 ·Status: COMPLETED ·Phase: PHASE3

Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies

NCT02118584 ·Status: TERMINATED ·Phase: PHASE3

Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD)

NCT03279081 ·Status: COMPLETED ·Phase: PHASE3

Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease

NCT01541579 ·Status: COMPLETED ·Phase: PHASE3

Visilizumab for Treatment of Perianal Fistulas in Crohn's Disease

NCT00267709 ·Status: COMPLETED ·Phase: PHASE2

Stop Infliximab in Patients With Crohn's Disease

NCT00571337 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease

NCT02877134 ·Status: COMPLETED ·Phase: PHASE2

A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis

NCT05796245 ·Status: COMPLETED

Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease

NCT00004941 ·Status: COMPLETED ·Phase: PHASE3

Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease

NCT03395184 ·Status: COMPLETED ·Phase: PHASE2

Study of the 12-month Efficacy of Stem Cell Injection in Crohn's Disease With Complex Ano-perineal Fistula

NCT05177003 ·Status: UNKNOWN

TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease

NCT06051253 ·Status: RECRUITING ·Phase: PHASE4

Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease

NCT00325078 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Precise Infliximab Exposure and Pharmacodynamic Control

NCT05660746 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Efficacy and Safety of Two Regimens of Maintenance Therapy in Children With Crohn Disease

NCT01559142 ·Status: UNKNOWN ·Phase: PHASE3

Efficacy and Safety Study of D9421-C 9 mg and 15 mg Versus Placebo in Japanese Patients With Active Crohn's Disease

NCT00573469 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Long-term Safety of Etrolizumab in Participants With Moderate to Severe Ulcerative Colitis

NCT01461317 ·Status: COMPLETED ·Phase: PHASE2